771562-91-5

Basic information

• Product Name: dimethyl [(1R)-1-(3-(cyclopentyloxy)-4-methoxyphenyl)-2-nitroethyl]propanedioate
• Synonyms: dimethyl [(1R)-1-(3-(cyclopentyloxy)-4-methoxyphenyl)-2-nitroethyl]propanedioate
• CAS NO: 771562-91-5
• Molecular Weight: 395.409
• Mol File: 771562-91-5.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: dimethyl [(1R)-1-(3-(cyclopentyloxy)-4-methoxyphenyl)-2-nitroethyl]propanedioate(CAS DataBase Reference)
• NIST Chemistry Reference: dimethyl [(1R)-1-(3-(cyclopentyloxy)-4-methoxyphenyl)-2-nitroethyl]propanedioate(771562-91-5)
• EPA Substance Registry System: dimethyl [(1R)-1-(3-(cyclopentyloxy)-4-methoxyphenyl)-2-nitroethyl]propanedioate(771562-91-5)

Safety Data

• Hazardous Substances Data: 771562-91-5(Hazardous Substances Data)

Upstream product

• 108-59-8 malonic acid dimethyl ester 
• 133332-47-5 2-(cyclopentyloxy)-1-methoxy-4-[(E)-2-nitroethenyl]benzene 
• 141332-74-3 2-(cyclopentyloxy)-1-methoxy-4-(2-nitrovinyl)benzene 
• 75-52-5 nitromethane 
• 67387-76-2 3-cyclopentyloxy-4-methoxybenzylaldehyde 

Relevant articles and documents

Catalytic enantioselective Michael addition of 1,3-dicarbonyl compounds to nitroalkenes catalyzed by well-defined chiral Ru amido complexes

Well-defined chiral Ru amido complexes promoted asymmetric Michael addition of 1,3-dicarbonyl compounds including malonates, β-keto esters, and 1,3-diketones to nitroalkenes to give the corresponding adducts with excellent ees and in excellent yields. Cop

Asymmetric synthesis of 3-prenyl-substituted pyrrolidin-2-ones

Pharmacology-relevant compounds bearing structural fragments of racetam nootropics, wound-healing acyclic isoprenoids and neurotropic GABA analogues, were enantioselectively (up to 94% ee) synthesized from available and inexpensive precursors.

Multisite organic-inorganic hybrid catalysts for the direct sustainable synthesis of GABAergic drugs

Multisite organic-inorganic hybrid catalysts have been prepared and applied in a new general, practical, and sustainable synthetic procedure toward industrially relevant GABA derivatives. The domino sequence is composed of seven chemical transformations which are performed in two one-pot reactions. The method produces both enantiomeric forms of the product in high enantiopurity as well as the racemate in good yields after a single column purification step. This protocol highlights major process intensification, catalyst recyclability, and low waste generation.